Type I interferon protects against pneumococcal invasive disease by inhibiting bacterial transmigration across the lung.
Streptococcus pneumoniae infection is a leading cause of bacterial pneumonia, sepsis and meningitis and is associated with high morbidity and mortality. Type I interferon (IFN-I), whose contribution to antiviral and intracellular bacterial immunity is well established, is also elicited during pneumo...
Guardado en:
Autores principales: | Kim S LeMessurier, Hans Häcker, Liying Chi, Elaine Tuomanen, Vanessa Redecke |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2fba4f496af54d92a578a2b456dc1feb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Transmigration program can be failed, but transmigrant stay life: Portraits of Transmigrant Families in Sorong Regency, West Papua
por: Irin Oktafiani, et al.
Publicado: (2020) -
Unveiling Unexpected Immune Activities Induced by Your Pneumococcal Vaccine
por: Julia L. Hurwitz, et al.
Publicado: (2016) -
Transmigrated Canines Associated to Odontomas
por: Salamanca,Carlos, et al.
Publicado: (2017) -
Dynamic capsule restructuring by the main pneumococcal autolysin LytA in response to the epithelium
por: Colin C. Kietzman, et al.
Publicado: (2016) -
Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study.
por: Zitta B Harboe, et al.
Publicado: (2009)